Get started
Author

Long Chen

Observed names: Chen, Long, Long Chen, PhD
ORCID: 0000-0002-3304-3707
Observed ORCID: 0000-0002-3304-3707
OpenAlex ID: A5076058533
Combination therapy with immune checkpoint inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: A meta-analysis
2023 · Long Chen, Dun-Chang Mo, et al. · International Immunopharmacology · 13
Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis
2022 · Long Chen, Yi-Chang Li, et al. · Medicine · 3
Overtreatment risk of postoperative radiotherapy in FIGO I–III cervical small cell neuroendocrine carcinoma: a population-based study
2026 · Dun-Chang Mo, Jian-Feng Huang, et al. · Frontiers in Endocrinology
PDF
Analysis code for: Beyond compound ranking, the HDAC-inhibitor class is the reproducible butyrate-mimicking axis in nasopharyngeal carcinoma cells, with replication in independent pharmacogenomic panels
2026 · Chen, Long, Tang, Siying, et al. · Zenodo (CERN European Organization for Nuclear Research)
Biologics versus surgery in chronic rhinosinusitis with nasal polyps: a network meta-analysis
2026 · Long Chen, PhD · Open Science Framework
Works count: 5
Citation count: 16
H-index: 2
I10-index: 1
Year
Topic
Type